Viveve to Host Conference Call to Provide Corporate Update and Second Quarter 2019 Results on August 8, 2019

Viveve to Host Conference Call to Provide Corporate Update and Second Quarter 2019 Results on August 8, 2019

5 years ago
Anonymous $9jpehmcKty

https://www.accesswire.com/554317/Viveve-to-Host-Conference-Call-to-Provide-Corporate-Update-and-Second-Quarter-2019-Results-on-August-8-2019

ENGLEWOOD, CO / ACCESSWIRE / August 1, 2019 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women’s intimate health, today announced that it will report its second quarter 2019 financial results after the close of the U.S. financial markets on Thursday, August 8, 2019, and will host a live conference call and webcast to provide a corporate update at 4:30 PM ET the same day.

The conference call may be accessed by dialing 1-833-255-2833 (domestic) or 1-412-902-6728 (international) or via live webcast at https://services.choruscall.com/links/vive190808.html. Participants may also pre-register for the conference call at http://dpregister.com/10133641.

Viveve to Host Conference Call to Provide Corporate Update and Second Quarter 2019 Results on August 8, 2019

Aug 1, 2019, 9:24pm UTC
https://www.accesswire.com/554317/Viveve-to-Host-Conference-Call-to-Provide-Corporate-Update-and-Second-Quarter-2019-Results-on-August-8-2019 > ENGLEWOOD, CO / ACCESSWIRE / August 1, 2019 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women’s intimate health, today announced that it will report its second quarter 2019 financial results after the close of the U.S. financial markets on Thursday, August 8, 2019, and will host a live conference call and webcast to provide a corporate update at 4:30 PM ET the same day. > The conference call may be accessed by dialing 1-833-255-2833 (domestic) or 1-412-902-6728 (international) or via live webcast at https://services.choruscall.com/links/vive190808.html. Participants may also pre-register for the conference call at http://dpregister.com/10133641.